Analyst report boosted United Therapeutics' price target from $525 to $625.

The entities involved

• United Therapeutics →

  biotech company based in Silver Spring, Maryland, United States

  • Mirum Pharmaceuticals and United Therapeutics are being compared as healthcare companies.03:20
  • United Therapeutics completed facility construction in Minnesota and Texas and submitted an NDA to the FDA.Fri 19:57
• Cantor Fitzgerald →

  American financial services company

  • Agilysys CEO Ramesh Srinivasan sold significant company shares, with the transaction disclosed via filings with the SEC, concurrent with a rating from Cantor Fitzgerald.06:06
  • Cantor Fitzgerald boosted its price target for Custom Truck One Source.Sat 05:58

Related events

• Analyst provides a high price target for Viking Therapeutics stock.Sep 3
• Bristol-Myers Squibb's price target was cut by Cantor Fitzgerald following clinical setbacks.Jun 7
• Cantor Fitzgerald and Benchmark issued rating and price target updates for First Financial Bankshares Inc.Oct 17
• Cantor Fitzgerald raised price targets and reaffirmed ratings, while TD Cowen adjusted its ratings for Paylocity on August 7, 2026.Aug 7
• Cantor Fitzgerald restated an overweight rating and Royal Bank of Canada reduced its price objective for United Therapeutics.Fri 05:24